# ALZEVIT: Nationwide Digital APOE ε4 Cohort for Early Alzheimer's Disease Prevention and Trial Readiness

> **NCT07679906** · — · RECRUITING · sponsor: **Firalis SA** · enrollment: 50000 (estimated)

## Conditions studied

- Alzheimer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07679906
- **Lead sponsor:** Firalis SA
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2027-05-01
- **Final completion:** 2028-05-01
- **Target enrollment:** 50000 (ESTIMATED)
- **Last updated:** 2026-09-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07679906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07679906, "ALZEVIT: Nationwide Digital APOE ε4 Cohort for Early Alzheimer's Disease Prevention and Trial Readiness". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07679906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*